123 related articles for article (PubMed ID: 31225497)
1. P4HA1 is a new regulator of the HIF-1 pathway in breast cancer.
Xu R
Cell Stress; 2019 Jan; 3(1):27-28. PubMed ID: 31225497
[TBL] [Abstract][Full Text] [Related]
2. Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance.
Xiong G; Stewart RL; Chen J; Gao T; Scott TL; Samayoa LM; O'Connor K; Lane AN; Xu R
Nat Commun; 2018 Oct; 9(1):4456. PubMed ID: 30367042
[TBL] [Abstract][Full Text] [Related]
3. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
4. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
[TBL] [Abstract][Full Text] [Related]
5. Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.
Davuluri G; Schiemann WP; Plow EF; Sossey-Alaoui K
JAKSTAT; 2014; 3(4):e1009276. PubMed ID: 26413422
[TBL] [Abstract][Full Text] [Related]
6. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
[TBL] [Abstract][Full Text] [Related]
7. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
[TBL] [Abstract][Full Text] [Related]
8. HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity.
Kuo CY; Cheng CT; Hou P; Lin YP; Ma H; Chung Y; Chi K; Chen Y; Li W; Kung HJ; Ann DK
Oncotarget; 2016 Jun; 7(23):34052-69. PubMed ID: 27058900
[TBL] [Abstract][Full Text] [Related]
9. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
Koo JS; Jung W
Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
[TBL] [Abstract][Full Text] [Related]
10. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer
Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY
World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277
[TBL] [Abstract][Full Text] [Related]
12. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 (HIF-1) pathway.
Semenza GL
Sci STKE; 2007 Oct; 2007(407):cm8. PubMed ID: 17925579
[TBL] [Abstract][Full Text] [Related]
14. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
15. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro.
Tanaka T; Ikegami Y; Nakazawa H; Kuriyama N; Oki M; Hanai J; Sukhatme VP; Kaneki M
J Cell Physiol; 2017 Jan; 232(1):192-201. PubMed ID: 27137755
[TBL] [Abstract][Full Text] [Related]
17. Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells
Cecil DL; Slota M; O'Meara MM; Curtis BC; Gad E; Dang Y; Herendeen D; Rastetter L; Disis ML
Clin Cancer Res; 2017 Jul; 23(13):3396-3404. PubMed ID: 28039264
[No Abstract] [Full Text] [Related]
18. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E
Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513
[TBL] [Abstract][Full Text] [Related]
19. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
20. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]